Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Melero

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Journal of Hazardous Materials|November 20, 2019
Contamination of N-poor wastewater with emerging pollutants does not affect the performance of purple phototrophic bacteria and the subsequent resource recovery potentialI de Las Heras, R Molina, Y Segura, et al.
Virology|July 20, 2002
Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segmentM Begoña Ruiz-Argüello, Luis González-Reyes, Leslie J Calder, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2001
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusionL González-Reyes, M B Ruiz-Argüello, B García-Barreno, et al.
Immunotherapy|July 20, 2010
Clinical development of combination strategies in immunotherapy: are we ready for more than one investigational product in an early clinical trial?Jose L Perez-Gracia, Pedro Berraondo, Ivan Martinez-Forero, et al.
The Journal of General Virology|November 24, 2004
Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanismM Begoña Ruiz-Argüello, Diana Martín, Steve A Wharton, et al.
Water Research|July 19, 2013
Coupling membrane separation and photocatalytic oxidation processes for the degradation of pharmaceutical pollutantsF Martínez, M J López-Muñoz, J Aguado, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus InfectionLaurent Detalle, Thomas Stohr, Concepción Palomo, et al.
Journal of Virology|August 1, 2014
A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopesKurt A Swanson, Kara Balabanis, Yuhong Xie, et al.
Mbio|February 21, 2019
Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry MechanismS F Bottom-Tanzer, K Rybkina, J N Bell, et al.
Cell and Tissue Banking|September 22, 2021
Microbiological assessment of arterial allografts processed in a tissue bankV Mirabet, M Arrébola, J Briones, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Journal of Hazardous Materials|November 20, 2019
Contamination of N-poor wastewater with emerging pollutants does not affect the performance of purple phototrophic bacteria and the subsequent resource recovery potentialI de Las Heras, R Molina, Y Segura, et al.
Virology|July 20, 2002
Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segmentM Begoña Ruiz-Argüello, Luis González-Reyes, Leslie J Calder, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 9, 2001
Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusionL González-Reyes, M B Ruiz-Argüello, B García-Barreno, et al.
Immunotherapy|July 20, 2010
Clinical development of combination strategies in immunotherapy: are we ready for more than one investigational product in an early clinical trial?Jose L Perez-Gracia, Pedro Berraondo, Ivan Martinez-Forero, et al.
The Journal of General Virology|November 24, 2004
Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanismM Begoña Ruiz-Argüello, Diana Martín, Steve A Wharton, et al.
Water Research|July 19, 2013
Coupling membrane separation and photocatalytic oxidation processes for the degradation of pharmaceutical pollutantsF Martínez, M J López-Muñoz, J Aguado, et al.
Antimicrobial Agents and Chemotherapy|October 7, 2015
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus InfectionLaurent Detalle, Thomas Stohr, Concepción Palomo, et al.
Journal of Virology|August 1, 2014
A monomeric uncleaved respiratory syncytial virus F antigen retains prefusion-specific neutralizing epitopesKurt A Swanson, Kara Balabanis, Yuhong Xie, et al.
Mbio|February 21, 2019
Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry MechanismS F Bottom-Tanzer, K Rybkina, J N Bell, et al.
Cell and Tissue Banking|September 22, 2021
Microbiological assessment of arterial allografts processed in a tissue bankV Mirabet, M Arrébola, J Briones, et al.
Pageof 18